The U.S. housing market is cooling this summer, marked by a rise in price adjustments and a ninth consecutive month of annual list-price declines. Despite the softening, the sector is avoiding a collapse, with pending home sales recording their eighth straight month of growth as buyers remain active but increasingly selective.
When scammers cloned the voice and likeness of lipedema surgeon Dr. David Amron to hawk fake medical creams, it signaled a new, dangerous frontier in fraud. On July 29, 2026, Amron brought his firsthand experience to the U.S. Senate Special Committee on Aging, urging lawmakers to confront AI-enabled medical impersonation.
National Energy Services Reunited Corp. will report its financial performance for the second quarter of 2026 on August 10. The Houston-based energy services firm, which operates extensively across the Middle East and North Africa, plans to host an investor conference call shortly after the morning release.
Loews Corporation reported net income of $444 million for the second quarter of 2026, marking a significant rise from the $391 million recorded during the same period last year. Earnings per share reached $2.16, bolstered by strong performances across the company’s hospitality and energy infrastructure divisions.
FMG Suite is aggressively scaling its leadership team, tapping senior talent from firms including Goldman Sachs, Salesforce, and EY-Parthenon. The move signals a strategic shift for the marketing platform as it pivots toward enterprise-level wealth management, embedding AI-driven capabilities into its core compliant growth infrastructure.
Mikael Dolsten, the longtime Chief Scientific Officer who steered Pfizer’s R&D pipeline through 36 successful drug and vaccine approvals, has joined the board of Varda Space Industries. His appointment signals a strategic shift for the El Segundo startup as it transitions from orbital testing to commercial pharmaceutical production.
Atlanta-based IT services provider BlueAlly has acquired Miami-based GigaNetworks, a firm specializing in enterprise network security and infrastructure. The move aims to merge BlueAlly’s national operational scale with GigaNetworks’ deep technical expertise, creating a unified platform focused on streamlining complex security deployments for corporate clients across the United States.
Chicago-based insurer CNA Financial Corporation posted a second-quarter net income of $321 million, or $1.18 per share, marking an increase over the $299 million recorded during the same period last year, even as core income saw a slight dip to $324 million amid ongoing underwriting challenges.
Testing mobile applications against generic device banks often fails to capture real-world user conditions. Appdome is attempting to solve this with Appdome Test, a new capability that integrates validation directly into the mobile protection pipeline, matching test devices and operating systems to a brand's actual install base.
Target is entering the culinary publishing space with the release of "Good & Gather: Discover Delicious Every Day," a collection of 100 recipes designed for busy households. The cookbook aims to cement the retailer's position as a food destination by utilizing ingredients exclusively sourced from its own aisles.
Shanghai-based pharmaceutical giant WuXi AppTec reported a 38.9% revenue surge to RMB 28.90 billion for the first half of 2026, prompting the company to raise its full-year financial guidance as its integrated CRDMO platform continues to benefit from the commercial success of its customers' drug products.
Hyperscale Data has secured approximately $30 million in financing through the Morpho Protocol, leveraging its Bitcoin treasury as collateral to fund the expansion of its Michigan AI data center. The move marks a strategic shift toward using decentralized finance to access capital while retaining long-term digital asset exposure.
AusperBio Therapeutics has dosed the first patient in a clinical study for AHB-171, an investigational siRNA therapeutic designed to treat chronic hepatitis B. This milestone marks the first clinical application of the company's proprietary Au-HALO liver-targeting platform, expanding its pipeline beyond its existing lead program, AHB-137.
The United States currently imports nearly all of its merchant pig iron, a strategic vulnerability that MagIron aims to close by establishing large-scale domestic production. A new economic study from Primetals Technologies confirms that MagIron’s existing infrastructure could support an output of two million tonnes per year.
The 2026 World Dairy Industry Conference opened in Hohhot, Inner Mongolia, on August 1, as the International Union of Food Science and Technology formally designated the city the World Dairy Capital. Hosted by Yili Group, the gathering focuses on accelerating technological integration and cross-border partnerships across the global dairy value chain.
Hundreds of young innovators gathered at the Pan Am Centre in Markham, Ontario, from July 18 to 20 for the inaugural ENJOY AI 2026 Americas Open. The event drew students from Canada, Mexico, Türkiye, and Ethiopia, marking a significant expansion for the international robotics and STEM competition network.
Investors who purchased Regeneron Pharmaceuticals stock between August 1, 2025, and May 15, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders regarding the clinical success of its Phase III Fianlimab-Libtayo study by utilizing flawed statistical assumptions.
With 1,006 patients enrolled across seven medical centers, Invenio Imaging has finalized the ON-SITE study, a pivotal clinical trial testing an AI-based module designed to provide real-time assessment of lung biopsy specimens during bronchoscopic procedures, potentially solving long-standing diagnostic bottlenecks in the operating room.
For years, companies hiring internationally have faced unpredictable costs hidden behind opaque surcharges and FX markups. Multiplier, the Global Exchange for Work, is challenging this industry standard by publishing its complete Employer of Record pricing structure directly on its website, promising total cost predictability for finance and HR teams.
Scaling from 80 to 200 inches, the new Hisense PX4 Pro TriChroma Laser Cinema aims to bridge the gap between professional theater performance and living room utility. The device leverages a 3,500 ANSI lumen output to maintain image clarity during daylight hours while targeting both cinephiles and competitive gamers.
Banyan Group has expanded its flagship hospitality footprint in China with the launch of Banyan Tree Mount Emei. Located in the foothills of Sichuan’s revered sacred mountain, the 130-room resort integrates contemporary architecture with the natural topography of a forested valley, offering direct access to the UNESCO World Heritage site.
Transforming the living room into a theater, Hisense has launched the PX4 Pro, a TriChroma laser projector capable of casting images up to 200 inches. The device aims to bridge the gap between high-end professional cinema and everyday household utility, balancing daylight brightness with advanced gaming performance features.
HUMAIN has secured its first investment in a Saudi company by backing MOZN, an enterprise AI firm specializing in high-assurance sectors. The partnership aims to integrate HUMAIN’s full-stack infrastructure with MOZN’s engineering model to accelerate production-scale AI deployments for global financial institutions and government organizations.
A class action lawsuit filed in Los Angeles alleges that Wix.com misled shareholders regarding the competitive viability and development costs of its artificial intelligence tools. The litigation, which covers the period from February 2025 through May 2026, claims the company provided false information to the market throughout the class period.
Shareholders who held GPGI, Inc. stock between November 3, 2025, and May 6, 2026, face a September 15, 2026, deadline to join a class action lawsuit. The litigation centers on claims that the company misled investors regarding the financial health and valuation of its Husky Technologies Limited division.
Investors who held Insulet Corporation stock between February 21, 2025, and May 26, 2026, face an August 31 deadline to join a class action lawsuit. The litigation alleges the company misled the market regarding the integrity of its manufacturing processes and the safety of its medical devices.
Investors who held Insulet Corporation stock between February 21, 2025, and May 26, 2026, face an August 31, 2026, deadline to join a securities fraud class action. The lawsuit, filed by Schall Brown & Schwartz LLP, alleges the medical device manufacturer misled the market regarding its internal manufacturing controls and product safety.
Investors who purchased Planet Fitness, Inc. securities between November 6, 2025, and May 6, 2026, face a September 14, 2026, deadline to seek lead plaintiff status. Schall Brown & Schwartz LLP is currently organizing a class action lawsuit against the company for alleged violations of the Securities Exchange Act.
A New York-based investor rights firm is escalating its investigation into The Ensign Group, alleging the nursing home operator provided shareholders with materially misleading business information. The probe follows a sharp decline in share value prompted by claims of systemic understaffing and manipulated quality metrics at the company’s facilities.
Investors who purchased Regeneron Pharmaceuticals stock between August 1, 2025, and May 15, 2026, are facing a legal deadline of September 14, 2026, to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act following the disclosure of disappointing clinical trial results.
